plants


Supreme Cannabis: At the Epicenter of Premium Products

July 22nd, 2019 - Ash Stringer

The old Aesop axiom advises to be vigilant, for you can be known by the company that you keep. If that’s the case, then Supreme Cannabis (TSX:FIRE) (OTCQX:SPRWF) must feel pretty good, as it has surrounded itself with household names in the burgeoning cannabis industry, albeit in-house, through partnerships or association. In-House Supreme is not […]

RYAH Dose Measuring Vaporizer Hits U.S. Dispensary Shelves

July 15th, 2019 - Ryan Allway

NEW YORK, July 15, 2019 (GLOBE NEWSWIRE) — RYAH Medtech Inc. (“RYAH” or the “Company”), announced today that its dose-measuring smart vaporizer and proprietary cartridges have hit medical dispensary shelves in the United States. RYAH selected Sweetspot, a high-end medical dispensary located in Maryland for its flagship launch. “We are excited to see RYAH on […]

Mojave Jane’s California Cannabis Plan

July 15th, 2019 - Ryan Allway

When it comes to building brands in the cannabis space, it pays to be ahead of the curve. Mojave Jane(CSE:JANE) (formerly known as High Hampton Holdings) is a California-centric cannabis company that includes award winning CALIGOLD edibles,  along with manufacturing, distribution, and delivery operations that open the door to produce a host of cannabis products […]

How New Technology from Medical Experts is Simplifying Cannabis Compliance

July 11th, 2019 - Ryan Allway

As we know, a growing number of states have legalized medical and adult-use cannabis, creating a robust industry worth billions of dollars per year. The problem is that cannabis remains illegal on a federal level, which has left states to create a patchwork of ever changing regulations. These regulations can be challenging to any cannabis […]

Cannabis Companies Need to Take It From The Experts

July 10th, 2019 - Ryan Allway

2018 was a momentous year and real turning point for cannabis. Canada became the first G20 country to legalize full adult-use of marijuana. The FDA approved the first cannabis-based drug, Epidiolex for certain rare forms of epilepsy. In a different vertical, Congress passed the Farm Bill, legalizing industrial hemp, a non-intoxicating cousin of marijuana that […]

Israel: A Cannabis Pioneer Then…and Now

July 10th, 2019 - Ash Stringer

When it comes to cannabis, Israel proves that big things can come in small packages. While recreational marijuana remains illegal in Israel, a country about the size of New Hampshire, the government has been proactive in supporting cannabis research for decades while other countries stagnated in the darkness of cannabis prohibition.  In the U.S., cannabis […]

FluroTech: Know Your Product, Improve Your Profits

July 9th, 2019 - Ash Stringer

Regulations surrounding the legal sale of cannabis can be byzantine, to say the least. In North America alone, 33 U.S. states have their own rules about legal use of marijuana, albeit medicinal or recreational, while the plant remains illegal at the federal level. That is unless it contains less than 0.3% tetrahydrocannabinol (THCa), in which […]

Oldest U.S. Cannabis Retailer Goes Public with Big Expansion Plan

July 9th, 2019 - Ryan Allway

  The U.S. cannabis industry is projected to reach $50 billion by 2026, according to Cowen & Co., driven by the legalization of adult-use cannabis across a growing number of jurisdictions. California has already become the dominant force behind the country’s legal cannabis industry following the legalization of adult-use cannabis in 2016. The state generated […]

Sublime Launches California’s First Cannabis-Infused Freezer Pops

July 3rd, 2019 - Ryan Allway

By : Sublime Canna July 2, 2019 Category : CONSUMABLES Freaze ice pops will be available at dispensaries this month OAKLAND, Calif. – July 2, 2019 /Canna Newswire/ – Sublime, an award-winning cannabis manufacturing company located in Oakland, Calif., is launching its latest edible product: Freaze, a cannabis-infused freezer pop. Just in time for the heat […]

The Global Big Data Market Meets RYAH Medtech’s Unique Vaporizer

July 2nd, 2019 - Ash Stringer

  The output of analyzing large blocks of information, or “big data” as it is generally known, to identify trends is one of the most valuable commodities today. One of the beauties of big data is that it can pinpoint trends at all scales, from an individual to an entire country. Another is that it […]

Synthetic Cannabinoids: The Harbinger of Cannabis Pharmaceuticals

June 27th, 2019 - Ryan Allway

Many people hear the phrase ‘synthetic’ cannabinoids and immediately think of deadly designer drugs that have swept the recreational market. But synthetic cannabinoids refer to any cannabinoids that are created through chemical or biological processes other than the cultivation and extraction of cannabis plants. These processes could help make cannabinoids much cheaper and chemically-precise — […]

Cannabis Holding Companies Offer Diversification & Growth Potential

June 26th, 2019 - Ryan Allway

Suppose that you want to invest in a portfolio of cannabis companies. You could purchase an exchange-traded fund (ETF) or build your own portfolio by carefully selecting individual publicly-traded companies. While these are good approaches, you’re limited to publicly-traded companies and the valuations they’re assigned by the market. You can’t access privately-held companies at low […]

Taking A Bite Out of The Cannabis Edibles Market

June 24th, 2019 - Ryan Allway

Cannabis edibles and beverages have more than doubled their share of the overall cannabis market since 2011, according to data from ArcView Market Research and BDS Analytics, with revenue projected to grow from $1 billion in 2017 to $4.1 billion by 2022. Consumer appetite for edibles also appears to be rising as people seek out […]

DNA Genetics: A Leader in Cannabis Branding & Licensing

June 24th, 2019 - Ryan Allway

The cannabis industry is projected to reach $146.4 billion by 2025, according to Grand View Research, representing a 34.6% compound annual growth rate. While many companies are focused on cultivation and retail, these business models involve high capital expenditures to produce commoditized products. Investors may be better off looking at companies focused on branding and […]

Lesotho Deputy Prime Minister, Mr. Monyane Moleleki, to Join Halo and Ms. Mojela at European Cannabis Week

June 19th, 2019 - Ryan Allway

TORONTO Ms. Mojela to speak at Global Cannabis Partnership Launch in House of Commons Halo Labs Inc. (“Halo” or the “Company”) (NEO: HALO, OTCQX: AGEEF, Germany: A9KN) is pleased to announce that the Deputy Prime Minister of Lesotho, Mr. Monyane Moleleki will be joining CEO of Halo Labs Kiran Sidhu and Chairman of Bophelo Bioscience […]

Halo Labs Intends to Appoint Ms. Louisa Mojela as Chairman of the Board Upon Closing of Bophelo Bioscience Acquisition

June 19th, 2019 - Ryan Allway

Expected to Become First Ever African Business Woman to Chair a Publicly Traded Cannabis Company Halo Labs Inc. (“Halo” or the “Company”) (NEO: HALO, OTCQX: AGEEF, Germany: A9KN) is pleased to announce that upon closing of the previously announced acquisition of Bophelo Bioscience & Wellness (Pty) Ltd. (“Bophelo”) (the “Transaction”), the Company intends to appoint […]

Zenabis Chief Growing Officer Outlines Potential in Exclusive Interview

June 19th, 2019 - Ryan Allway

    Canada’s cannabis industry is projected to reach C$22.6 billion over the coming years, according to Deloitte, driven by the legalization of medical and adult-use cannabis. With concentrates and edibles anticipated later this year, licensed producers could reach new consumers that aren’t interested in smoking cannabis. Investors may want to take a closer look […]

7 Minutes with Matt Willer and a Little Cannabis Alliteration

June 18th, 2019 - Ash Stringer

  Marcus Lemonis, the iconic entrepreneurial Profit, is famously known for building successful businesses under the mantra of “people, process and product.” If there is a company employing the “3 P’s” recipe in the cannabis space, it’s STWC Holdings Inc. (OTCQB: STWC), or Strainwise Consulting as it is often called, a company steeped with experience […]

FSD Pharma Continues to Add Expert Advisors Amid Buildout of Massive Facility

June 14th, 2019 - Ryan Allway

FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) has been focused on building out its board of directors and advisory board since becoming a full Canadian licensed producer earlier this year. After receiving its cultivation license in 2017, the company began work on a massive cultivation facility that could house nearly four million sq. ft. on […]

Rubicon Steps Up to the Cannabis Branding Plate

June 13th, 2019 - Robin Lefferts

  In the rapidly-evolving legal cannabis industry, we’ve gone from complete prohibition to limited medical markets to widespread retail markets in a few short years. In order for licensed producers to compete in the retail marketplace, the need to develop powerful consumer brands has become an incredibly important step for success. Companies that manage to […]

DehydraTECH: The Cynosure of Efficient CBD Delivery

June 13th, 2019 - Ash Stringer

Scientists use words like “bioavailability,” “pharmacokinetics” and “targeted” in describing keys to efficiently treating disease and conditions. To the patient, it is just swallowing a pill, but there is years of research that goes into improving drug delivery with the goal of getting the medicine to the right spot as quickly as possible to maximize […]

FinCanna’s QVI Looks to Become California’s Premier Contract Manufacturer

June 13th, 2019 - Ryan Allway

California’s cannabis industry is projected to reach $7.7 billion in revenue by 2021, according to *BDS Analytics and Arcview Group, driven by the legalization of adult-use cannabis. Within this market, manufactured products, edibles, and concentrates have outpaced cannabis flower to become the *fastest growing segment of the market. Concentrates can be incorporated into many different […]

The Unique Advantages, and Challenges, of Multi-State Operators

June 12th, 2019 - Tony Deyes

As the cannabis industry continues to mature, an increasing number of companies are choosing to become multi-state operators, with assets and operations in a number of US legal markets. Most have achieved this through the acquisition of companies with existing assets and licenses in target states, which most often become regional subsidiaries, allowing companies to […]

Israel Builds Dominant Position in the Global Medical Cannabis Industry

June 12th, 2019 - Ryan Allway

Israel has always been a leader in cannabis research and development—thanks to Raphael Mechoulam’s groundbreaking research—but it’s just starting to realize the potential for cultivation. In addition to having one of the highest per capita usage rates in the world, Israel is expected to soon have upwards of 50,000 patients on a waitlist and is […]

FSD Pharma Brings in World-Renowned Experts to Build Bioscience Division

June 4th, 2019 - Ryan Allway

The cannabis industry is quickly maturing from home grows and bongs to industrial-scale cultivation and innovative new product formats. At the core of this transformation, science is helping transform medical cannabis into cutting-edge pharmaceuticals and recreational cannabis into compelling alternatives to tobacco and alcohol. Companies that recognize the role of science are best positioned to […]

Cannabis Pioneer Strainwise Takes an Innovative Approach to the Industry

June 4th, 2019 - Ryan Allway

STWC Holdings Inc. (OTCQB: STWC), better known as Strainwise®, was founded by two cannabis industry pioneers that aim to transform their consulting practice into a national cannabis enterprise. Co-founder/CEO Erin Phillips acquired the first recreational cannabis license in the world for one of her clients, The Annie’s: A STRAINWISE® Branded Dispensary in Central City, Colorado. […]

FinCanna Combines Investment & Industry Expertise to Capitalize on California

June 4th, 2019 - Ryan Allway

California’s cannabis industry is projected to reach $7.7 billion by 2022, according to BDS Analytics and Arcview Group, making it the largest medical and recreational cannabis market in North America. While there are many different investment opportunities in the state, the best companies have innovative business models that avoid future commoditization issues and maximize scalability […]

How Celebrities & Politicians Help Build Cannabis Brands

May 31st, 2019 - Ryan Allway

There’s no doubt that celebrities can have a significant influence on a brand, particularly when it comes to Gen Z and Millennial demographics. At the same time, politicians can lend an air of credibility and provide valuable insights into the regulatory future of a market. These attributes have made them invaluable to cannabis companies that […]

The CBD Cosmeceutical Boom

May 31st, 2019 - Joy Crosby

As a new industry, the next few months will be pivotal for the development of the cannabis market. With laws changing every month in jurisdictions around the globe, the room for growth is huge as the industry continues to mature. A recent study by Statista showed that in 2018, the global sales of hemp amounted […]

Halo Labs: Building a Cannabis Concentrates Empire

May 29th, 2019 - Ryan Allway

Cannabis concentrates are projected to reach $8 billion by 2022, according to BDS Analytics and Arcview Market Research, making it the fastest growing of the three major segments of the legal cannabis market (flower, concentrates, and edibles). In particular, vaporizers sales soared from less than $100 million in 2014 to more than half of total […]


Network Partners

Follow Us on Social Media

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading